Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Infect Dis Rep ; 16(1): 83-92, 2024 Jan 26.
Article in English | MEDLINE | ID: mdl-38391584

ABSTRACT

Lophomonas are flagellated protozoa that have been increasingly associated with upper and lower airway infection in humans. The prevalence and characterization of this disease in the critically ill remains poorly understood. We present a series of eleven ICU patients with confirmed Lophomonas spp. identification in respiratory samples.

2.
ARP Rheumatol ; 2(3): 269-274, 2023.
Article in English | MEDLINE | ID: mdl-37839034

ABSTRACT

Cytomegalovirus (CMV) infection is a common and typically benign disease in immunocompetent individuals. However, immunocompromised patients are at a greater risk of reactivation, leading to more severe outcomes. Patients with rheumatic diseases have a particularly high risk of opportunistic infections due to both the inherent immunosuppressive state conveyed by the disease itself and the use of potent immunosuppressant drugs, such as glucocorticoids, cyclophosphamide, and rituximab. Limited data are available regarding prophylactic or preemptive treatment of CMV infection in patients with rheumatic diseases. In this article the authors present two cases of rheumatic conditions complicated by CMV infection. The first case describes a patient with eosinophilic granulomatosis with polyangiitis, previously treated with glucocorticoids and cyclophosphamide, who developed CMV colitis with bowel perforation. The second case involves a woman with systemic lupus erythematosus who was diagnosed with CMV meningitis. Both cases reinforce the importance of establishing guidelines for surveillance and prophylaxis of CMV infection in these patients.


Subject(s)
Churg-Strauss Syndrome , Cytomegalovirus Infections , Granulomatosis with Polyangiitis , Opportunistic Infections , Rheumatic Diseases , Female , Humans , Churg-Strauss Syndrome/chemically induced , Cyclophosphamide/therapeutic use , Cytomegalovirus/physiology , Cytomegalovirus Infections/complications , Glucocorticoids/therapeutic use , Granulomatosis with Polyangiitis/chemically induced , Immunosuppressive Agents/adverse effects , Opportunistic Infections/chemically induced , Rheumatic Diseases/complications
3.
PLoS One ; 16(6): e0253739, 2021.
Article in English | MEDLINE | ID: mdl-34191834

ABSTRACT

Methicillin-resistant Staphylococcus aureus (MRSA) has long been known as a major cause of hospital-acquired (HA-MRSA) infections worldwide. For the past twenty years, an increasing number of studies have described its emergence in the community as well. In Portugal, a country with a high-prevalence of HA-MRSA, there are only limited data available on the epidemiology of MRSA in the community. We studied the prevalence of S. aureus and MRSA colonization among healthy adults in Portugal. Between February 2015 and December 2016, a longitudinal study was conducted in which 87 adults aged 25-50 years old were followed for six months. For each participant nasopharyngeal, oropharyngeal and saliva samples were obtained monthly and, in some cases, weekly. A total of 1,578 samples (n = 526 for each sampling site) were examined for the presence of S. aureus and MRSA by classical culture-based methods. Fifty-seven adults (65.5%) carried S. aureus at least once during the six months period of the study: 19.5% were persistent S. aureus carriers and 46.0% were intermittent carriers. Carriage rates per sampling site were 20.5% in nasopharynx, 18.3% in oropharynx, and 13.5% in saliva. Simultaneous screening of the three sampling sites increased detection of S. aureus, which overall occurred in 34.4% of the 526 sampling time-points. No MRSA were isolated. In conclusion, this study adds novel information about the MRSA scenario in the Portuguese community. Our results indicate that, in Portugal, MRSA does not seem to circulate among healthy adults without risk factors and therefore this age group does not constitute, at the current time, a reservoir of MRSA in the community.


Subject(s)
Carrier State/epidemiology , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Staphylococcal Infections/epidemiology , Adult , Carrier State/diagnosis , Carrier State/microbiology , Female , Humans , Longitudinal Studies , Male , Middle Aged , Nasopharynx/microbiology , Oropharynx/microbiology , Portugal/epidemiology , Prevalence , Saliva/microbiology , Staphylococcal Infections/diagnosis , Staphylococcal Infections/microbiology
SELECTION OF CITATIONS
SEARCH DETAIL
...